MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$36,876
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Sales
0
0
55*
-
Service revenue
0
0
0*
0
Cost of revenues
0
0
43*
-
Gross profit
0
0
12
0
General and administrative
34,776
31,335
22,907
25,795
Total operating expenses
34,776
31,335
22,907
25,795
Operation income
-34,776
-31,335
-22,895
-25,795
Other income
-
15,829
-
-
Interest expense
-
2,100
2,100
2,100
Loss from inventory impairment
-
0
174,745
-
Interest expense
2,100
-
-
-
Income tax provision
0
0
0
0
Net loss
-36,876
-17,606
-199,740
-27,895
Diluted EPS
0
0
-0.002
-
Diluted Average Shares
99,000,000
99,000,000
104,133,334
96,433,333
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$36,876
(-21.70%↓ Y/Y)
Operation income
-$34,776
(-23.32%↓ Y/Y)
Interest expense
$2,100
(0.00%↑ Y/Y)
Total operating
expenses
$34,776
(23.32%↑ Y/Y)
General and
administrative
$34,776
(23.32%↑ Y/Y)
Buy us a coffee
GOLDENWELL BIOTECH, INC. (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL)